<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">adair</journal-id><journal-title-group><journal-title xml:lang="ru">Аллергология и Иммунология в Педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Allergology and Immunology in Paediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-1175</issn><issn pub-type="epub">2712-7958</issn><publisher><publisher-name>Ассоциация детских аллергологов и иммунологов России</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53529/2500-1175-2024-3-54-64</article-id><article-id custom-type="elpub" pub-id-type="custom">adair-156</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Роль периостина как воспалительного маркера при бронхиальной астме у детей</article-title><trans-title-group xml:lang="en"><trans-title>The role of periostin as an inflammatory marker in bronchial asthma in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5533-0205</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белых</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belykh</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белых Наталья Анатольевна — д. м. н., доцент, заведующая кафедрой факультетской и поликлинической педиатрии с курсом педиатрии</p><p>390026, г. Рязань, ул. Высоковольтная, д. 9</p></bio><bio xml:lang="en"><p>Natalia Anatolyevna Belykh — Dr. Sci., Associate Professor, Head of the Department of Faculty and Polyclinic Pediatrics with the Course of Pediatrics</p><p>390026, Ryazan, Vysokovoltnaya str., 9</p></bio><email xlink:type="simple">nbelyh68@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9267-439X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пизнюр</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pisnyur</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пизнюр Инна Владимировна — ассистент кафедры факультетской и поликлинической педиатрии с курсом педиатрии</p><p>390026, г. Рязань, ул. Высоковольтная, д. 9</p></bio><bio xml:lang="en"><p>Inna Vladimirovna Pisnyur — Assistant of the Department of Faculty and Polyclinic Pediatrics with the Course of Pediatrics</p><p>390026, Ryazan, Vysokovoltnaya str., 9</p></bio><email xlink:type="simple">innaabramova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9742-4528</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифоров</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никифоров Александр Алексеевич — к. м. н., доцент, заведующий Центральной научно-исследовательской лабораторией</p><p>390026, г. Рязань, ул. Высоковольтная, д. 9</p></bio><bio xml:lang="en"><p>Alexander Alekseevich Nikiforov — Cand. Sci., Associate Professor, Head of the Central Research Laboratory</p><p>390026, Ryazan, Vysokovoltnaya str., 9</p></bio><email xlink:type="simple">a.nikiforov@rzgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6296-9034</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никифорова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikiforova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никифорова Лариса Владимировна — старший научный сотрудник Центральной научно-исследовательской лаборатории</p><p>390026, г. Рязань, ул. Высоковольтная, д. 9</p></bio><bio xml:lang="en"><p>Larisa Vladimirovna Nikiforova — Senior Researcher at the Central Research Laboratory</p><p>390026, Ryazan, Vysokovoltnaya str., 9</p></bio><email xlink:type="simple">a.nikiforov@rzgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Рязанский государственный медицинский университет имени академика И. П. Павлова» Министерства здравоохранения Российской Федерации</institution></aff><aff xml:lang="en"><institution>Ryazan State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2024</year></pub-date><volume>0</volume><issue>3</issue><elocation-id>54–64</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Белых Н.А., Пизнюр И.В., Никифоров А.А., Никифорова Л.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Белых Н.А., Пизнюр И.В., Никифоров А.А., Никифорова Л.В.</copyright-holder><copyright-holder xml:lang="en">Belykh N.A., Pisnyur I.V., Nikiforov A.A., Nikiforova L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://adair.elpub.ru/jour/article/view/156">https://adair.elpub.ru/jour/article/view/156</self-uri><abstract><p>Актуальность. Белок внеклеточного матрикса периостин, экспрессируемый в ряде тканей организма, рассматривается в качестве маркера воспаления Т-клеток 2-го типа и контроля БА.Цель. Изучить взаимосвязь концентрации периостина в сыворотке крови в зависимости от степени тяжести бронхиальной астмы и показателей функции внешнего дыхания у детей.Материалы и методы. Проведено поперечное (одномоментное) исследование, куда были включены 80 детей в возрасте от 6 до 17 лет (средний возраст 12±3,2 года), которые были разделены на 2 группы: 1-я — дети с бронхиальной астмой (n=40); 2-я — группа сравнения (n=40). Концентрацию периостина в сыворотке крови определяли методом ИФА. Спирографическое исследование проводилось на компьютерном спирометре Spirolab 1, MIR (Италия).Результаты. Медиана (Ме) периостина в 1-й группе была в пределах нормы (730,2 нг/мл), но статистически значимо превышала показатель 2-й группы (539,7 нг/мл, р&lt;0,05) и не зависела от возраста, длительности и степени тяжести БА, антропометрических показателей обследованных. Уровень периостина в сыворотке крови значимо коррелировал с частотой обострений заболевания в течение года (r=0,74, р=0,000), со статусом контроля астмы (r=0,32, р=0,04). Выявлена умеренная корреляция между уровнем периостина и ОФВ1 (r=−0,34; р=0,03).Заключение. У детей с БА медиана периостина в сыворотке крови возрастала пропорционально степени тяжести БА, контроля заболевания и частоты обострения заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. The extracellular matrix protein periostin, expressed in a number of body tissues, is considered as a marker of type 2 T cell inflammation and of asthma control.Objective. To study the relationship the serum periostin concentration in blood serum depending on the severity of asthma and indicators of respiratory function in children.Materials and methods. The cross-sectional (simultaneous) study included 80 children aged 6 to 17 years (average age 12±3.2), who were divided into 2 groups: 1st — children with asthma (n=40); 2nd — comparison group (n=40). The concentration of periostin in the blood serum was determined by the ELISA method. The spirographic study was performed on a computer spirometer Spirolab 1, MIR (Italy).Results. The Me of periostin in group 1 was within the normal range (730.2 ng/ml), but statistically significantly exceeded the indicator of group 2 (539.7 ng/ml, p&lt;0.05) and did not depend on the age, duration and severity of asthma, anthropometric parameters of the examined. The level of periostin in the blood serum significantly correlated with the frequency of exacerbations of the disease during the year (r=0.74, p=0.000), with the status of asthma control (r=0.32, p=0.04). A moderate correlation was found between the level of periostin and FEV1 (r=−0.34; p=0.03).Conclusions. In children with asthma, the median periostin in the blood serum increased in proportion to the severity of asthma, disease control and the frequency of exacerbation of the disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>периостин</kwd><kwd>бронхиальная астма</kwd><kwd>дети</kwd><kwd>спирометрия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>periostin</kwd><kwd>bronchial asthma</kwd><kwd>children</kwd><kwd>spirometry</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бронхиальная астма: федеральные клинические рекомендации по диагностике и лечению. 2021. 118 с.</mixed-citation><mixed-citation xml:lang="en">Bronchial asthma: federal clinical guidelines for diagnosis and treatment. 2021. 118 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Habib N., Pasha M.A., Dale D., Tang D.D. Current Understanding of Asthma Pathogenesis and Biomarkers. Cells. 2022; 11 (17): 2764. https://doi.org/10.3390/cells11172764.</mixed-citation><mixed-citation xml:lang="en">Habib N., Pasha M.A., Dale D., Tang D.D. Current Understanding of Asthma Pathogenesis and Biomarkers. Cells. 2022; 11 (17): 2764. https://doi.org/10.3390/cells11172764.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kunc P., Fabry J., Lucanska M., Pecova R. Biomarkers of Bronchial Asthma. Physiol Res. 2020; 69 (Suppl 1): S29–S34. https://doi.org/10.33549/physiolres.934398.</mixed-citation><mixed-citation xml:lang="en">Kunc P., Fabry J., Lucanska M., Pecova R. Biomarkers of Bronchial Asthma. Physiol Res. 2020; 69 (Suppl 1): S29–S34. https://doi.org/10.33549/physiolres.934398.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Oppenheimer J., Hoyte F.C.L, Phipatanakul W., et al. Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions. Ann Allergy Asthma Immunol. 2022; 129 (2): 169–180. https://doi.org/10.1016/j.anai.2022.02.021.</mixed-citation><mixed-citation xml:lang="en">Oppenheimer J., Hoyte F.C.L, Phipatanakul W., et al. Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions. Ann Allergy Asthma Immunol. 2022; 129 (2): 169–180. https://doi.org/10.1016/j.anai.2022.02.021.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Yavuz S.T., Bagci S., Bolat A., Akin O., Ganschow R. Association of serum periostin levels with clinical features in children with asthma. Pediatr Allergy Immunol. 2021; 32 (5): 937–944. https://doi.org/10.1111/pai.13444.</mixed-citation><mixed-citation xml:lang="en">Yavuz S.T., Bagci S., Bolat A., Akin O., Ganschow R. Association of serum periostin levels with clinical features in children with asthma. Pediatr Allergy Immunol. 2021; 32 (5): 937–944. https://doi.org/10.1111/pai.13444.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L., Guo T., Chen Y., Bian K. The Multiple Roles of Periostin in Non-Neoplastic Disease. Cells. 2023; 12 (1): 50. https://doi.org/10.3390/cells12010050.</mixed-citation><mixed-citation xml:lang="en">Yang L., Guo T., Chen Y., Bian K. The Multiple Roles of Periostin in Non-Neoplastic Disease. Cells. 2023; 12 (1): 50. https://doi.org/10.3390/cells12010050.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Izuhara K., Nunomura S., Nanri Y., et al. Periostin: An emerging biomarker for allergic diseases. Allergy. 2019; 74 (11): 2116–2128. https://doi.org/10.1111/all.13814.</mixed-citation><mixed-citation xml:lang="en">Izuhara K., Nunomura S., Nanri Y., et al. Periostin: An emerging biomarker for allergic diseases. Allergy. 2019; 74 (11): 2116–2128. https://doi.org/10.1111/all.13814.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Novosad J., Krčmová I., Bartoš V., et al. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy Dermatol Allergol. 2020 Apr; 37 (2): 240–249. https://doi.org/10.5114/ada.2020.94842.</mixed-citation><mixed-citation xml:lang="en">Novosad J., Krčmová I., Bartoš V., et al. Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps. Postepy Dermatol Alergol. 2020 Apr; 37 (2): 240–249. https://doi.org/10.5114/ada.2020.94842.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Yu L., Wang J., Liu K. Role of periostin in ECRS. Eur Arch Otorhinolaryngol. 2021; 278 (8): 2665–2672. https://doi.org/10.1007/s00405-020-06369-x.</mixed-citation><mixed-citation xml:lang="en">Yu L., Wang J., Liu K. Role of periostin in ECRS. Eur Arch Otorhinolaryngol. 2021; 278 (8): 2665–2672. https://doi.org/10.1007/s00405-020-06369-x.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Turczyn A., Pańczyk-Tomaszewska M. The role of periostin in kidney diseases. Cent Eur J Immunol. 2021; 46 (4): 494–501. https://doi.org/10.5114/ceji.2021.110317.</mixed-citation><mixed-citation xml:lang="en">Turczyn A., Pańczyk-Tomaszewska M. The role of periostin in kidney diseases. Cent Eur J Immunol. 2021; 46 (4): 494–501. https://doi.org/10.5114/ceji.2021.110317.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Krasilnikova S.V., Tush E.V., Frolov P.A., et al. Periostin as a Biomarker of Allergic Inflammation in Atopic Bronchial Asthma and Allergic Rhinitis (a Pilot Study). Sovrem Tekhnologii Med. 2021; 12 (5): 37–45. https://doi.org/10.17691/stm2020.12.5.04.</mixed-citation><mixed-citation xml:lang="en">Krasilnikova S.V., Tush E.V., Frolov P.A., et al. Periostin as a Biomarker of Allergic Inflammation in Atopic Bronchial Asthma and Allergic Rhinitis (a Pilot Study). Sovrem Tekhnologii Med. 2021; 12 (5): 37–45. https://doi.org/10.17691/stm2020.12.5.04.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Шаханов А.В., Никифоров А.А., Урясьев О.М. Полиморфизм генов синтаз оксида азота (NOS1 84G/A И NOS3 786C/T) у больных бронхиальной астмой и гипертонической болезнью. Российский медико-биологический вестник им. академика И. П. Павлова. 2017; 25 (3): 378–390. https://doi.org/10.23888/PAVLOVJ20173378-390.</mixed-citation><mixed-citation xml:lang="en">Shakhanov A.V., Nikiforov A.A., Uryazyev O.M. Polymorphism of nitric oxide synthase genes (NOS1 84G/A and NOS3 786C/T) in patients with bronchial asthma and hypertension. I. P. Pavlov Russian Medical Biological Herald. 2017; 25 (3): 378–390. https://doi.org/10.23888/PAVLOVJ20173378-390. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dorafshan S., Razmi M., Safaei S., et al. Periostin: biology and function in cancer. Cancer Cell Int. 2022; 22 (1): 315. https://doi.org/10.1186/s12935-022-02714-8.</mixed-citation><mixed-citation xml:lang="en">Dorafshan S., Razmi M., Safaei S., et al. Periostin: biology and function in cancer. Cancer Cell Int. 2022; 22 (1): 315. https://doi.org/10.1186/s12935-022-02714-8.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sonnenberg-Riethmacher E., Miehe M., Riethmacher D. Periostin in Allergy and Inflammation. Front Immunol. 2021; 27: 12: 722170. https://doi.org/10.3389/fimmu.2021.722170.</mixed-citation><mixed-citation xml:lang="en">Sonnenberg-Riethmacher E., Miehe M., Riethmacher D. Periostin in Allergy and Inflammation. Front Immunol. 2021; 27: 12: 722170. https://doi.org/10.3389/fimmu.2021.722170.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Asano T., Ohbayashi H., Ariga M., et al. Serum periostin reflects dynamic hyperinflation in patients with asthma. ERJ Open Res. 2020; 6 (2): 00347–2019. https://doi.org/10.1183/23120541.00347-2019.</mixed-citation><mixed-citation xml:lang="en">Asano T., Ohbayashi H., Ariga M., et al. Serum periostin reflects dynamic hyperinflation in patients with asthma. ERJ Open Res. 2020; 6 (2): 00347–2019. https://doi.org/10.1183/23120541.00347-2019.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar K., Singh M., Mathew J.L., et al. Serum Periostin Level in Children with Asthma. Indian J Pediatr. 2023; 90 (5): 438–442. https://doi.org/10.1007/s12098-022-04282-1.</mixed-citation><mixed-citation xml:lang="en">Kumar K., Singh M., Mathew J.L., et al. Serum Periostin Level in Children with Asthma. Indian J Pediatr. 2023; 90 (5): 438–442. https://doi.org/10.1007/s12098-022-04282-1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Global Strategy for Asthma Management and Prevention. Updated 2022. https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf.</mixed-citation><mixed-citation xml:lang="en">Global Strategy for Asthma Management and Prevention. Updated 2022. https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Scichilone N., Crimi C., Benfante A., et al. Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics. Asthma Res Pract. 2016; 2: 1. https://doi.org/10.1186/s40733-015-0019-x.</mixed-citation><mixed-citation xml:lang="en">Scichilone N., Crimi C., Benfante A., et al. Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics. Asthma Res Pract. 2016; 2: 1. https://doi.org/10.1186/s40733-015-0019-x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization, Asthma Key Facts. URL: https://www.who.int/news-room/fact-sheets/detail/asthma.</mixed-citation><mixed-citation xml:lang="en">World Health Organization, Asthma Key Facts. URL: https://www.who.int/news-room/fact-sheets/detail/asthma.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Каменева М.Ю., Черняк А.В., Айсанов З.Р. и др. Спирометрия: методическое руководство по проведению исследования и интерпретации результатов. Пульмонология. 2023; 33 (3): 307–340. https://doi.org/10.18093/08690189-2023-33-3-307-340.</mixed-citation><mixed-citation xml:lang="en">Kameneva M.Y., Chernyak A.V., Aisanov Z.R. et al. Spirometry: a methodological guide for conducting research and interpreting the results. Pulmonology. 2023; 33 (3): 307–340. https://doi.org/10.18093/08690189-2023-33-3-307-340. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue T., Akashi K., Watanabe M., et al. Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol. 2016; 27 (5): 521–526. https://doi.org/10.1111/pai.12575.</mixed-citation><mixed-citation xml:lang="en">Inoue T., Akashi K., Watanabe M., et al. Periostin as a biomarker for the diagnosis of pediatric asthma. Pediatr Allergy Immunol. 2016; 27 (5): 521–526. https://doi.org/10.1111/pai.12575.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Song J.S., You J.S., Jeong S.I., et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015; 70 (6): 674–681. https://doi.org/10.1111/all.12599.</mixed-citation><mixed-citation xml:lang="en">Song J.S., You J.S., Jeong S.I., et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy. 2015; 70 (6): 674–681. https://doi.org/10.1111/all.12599.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Масальский С.С., Калмыкова А.С., Уханова О.П. Комплексная оценка сывороточного периостина — нового маркера аллергического воспаления при неконтролируемой БА у детей. Российский Аллергологический Журнал. 2018; 15 (1S): 55–57. https://doi.org/10.36691/RJA49.</mixed-citation><mixed-citation xml:lang="en">Masalskiy S.S., Kalmykova A.S., Ukhanova O.P. Сomplex evaluation of serum periostin — new marker of allergic inflammation at uncontrolled bronchial asthma at children. Russian Journal of Allergy. 2018; 15 (1S): 55–57. https://doi: https://doi.org/10.36691/RJA49. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">El Basha N.R., Osman H.M., Abdelaal A.A., et al. Increased expression of serum periostin and YKL40 in children with severe asthma and asthma exacerbation. J Investig Med. 2018; 66: 1102–1108. https://doi.org/10.1136/jim-2017-000680.</mixed-citation><mixed-citation xml:lang="en">El Basha N.R., Osman H.M., Abdelaal A.A., et al. Increased expression of serum periostin and YKL40 in children with severe asthma and asthma exacerbation. J Investig Med. 2018; 66: 1102–1108. https://doi.org/10.1136/jim-2017-000680.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Habernau Mena A., Del Pozo A.V., Rodriguez Vidigal F.F., et al. Role of periostin in uncontrolled asthma in children (DADO study). J Investig Allergol Clin Immunol. 2017; 27: 291–298. https://doi.org/10.18176/jiaci.0144.</mixed-citation><mixed-citation xml:lang="en">Habernau Mena A., Del Pozo A.V., Rodriguez Vidigal F.F., et al. Role of periostin in uncontrolled asthma in children (DADO study). J Investig Allergol Clin Immunol. 2017; 27: 291–298. https://doi.org/10.18176/jiaci.0144.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Licari A., Brambilla I., Sacchi L., Marseglia G., Ciprandi G. Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children. Respir Med. 2019; 151: 118–120. https://doi.org/10.1016/j.rmed.2019.04.010.</mixed-citation><mixed-citation xml:lang="en">Licari A., Brambilla I., Sacchi L., Marseglia G., Ciprandi G. Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children. Respir Med. 2019; 151: 118–120. https://doi.org/10.1016/j.rmed.2019.04.010.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kimura H., Konno S., Makita H., et al. Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects. Allergol Int. 2018; 67: 357–363. https://doi.org/10.1016/j.alit.2017.11.006.</mixed-citation><mixed-citation xml:lang="en">Kimura H., Konno S., Makita H., et al. Serum periostin is associated with body mass index and allergic rhinitis in healthy and asthmatic subjects. Allergol Int. 2018; 67: 357–363. https://doi.org/10.1016/j.alit.2017.11.006.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Shirai T., Hirai K., Gon Y., et al. Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap. J Allergy Clin Immunol: Pract. 2019; 7 (1): 134–145.e1. https://doi.org/10.1016/j.jaip.2018.06.015.</mixed-citation><mixed-citation xml:lang="en">Shirai T., Hirai K., Gon Y., et al. Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap. J Allergy Clin Immunol: Pract. 2019; 7 (1): 134–145.e1. https://doi.org/10.1016/j.jaip.2018.06.015.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Бяловский Ю.Ю., Ракитина И.С. Влияние исходной величины подкрепления на физиологические показатели условного дыхательного рефлекса. Наука молодых. 2021; (3): 377–386. https://doi.org/10.23888/HMJ202193377-386.</mixed-citation><mixed-citation xml:lang="en">Byalovsky Yu.Yu., Rakitina I.S. The effect of the initial reinforcement value on the physiological parameters of the conditioned respiratory reflex. Eruditio Juvenium. 2021; (3): 377–386. (In Russ.). https://doi.org/10.23888/HMJ202193377-386.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
